Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Double-Masked, Saline-Controlled Trial to Evaluate Corneal Endothelial Cell Density in Subjects With Dry Eye Disease Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.
Conditions
Interventions
Miebo
Saline
Locations
12
United States
Site 101
Glendale, California, United States
Site 112
Murrieta, California, United States
Site 102
Newport Beach, California, United States
Site 109
Rancho Cordova, California, United States
Site 106
Torrance, California, United States
Site 113
Delray Beach, Florida, United States
Start Date
July 31, 2024
Primary Completion Date
November 1, 2025
Completion Date
November 1, 2025
Last Updated
December 17, 2024
NCT07463950
NCT07363824
NCT07396441
NCT05865457
NCT05865379
NCT07366944
Lead Sponsor
Bausch & Lomb Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions